374 related articles for article (PubMed ID: 19491686)
1. The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden.
Ringborg A; Yin DD; Martinell M; Stålhammar J; Lindgren P
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):576-82. PubMed ID: 19491686
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).
Martin S; Schramm W; Schneider B; Neeser K; Weber C; Lodwig V; Heinemann L; Scherbaum WA; Kolb H
Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):495-501. PubMed ID: 17853332
[TBL] [Abstract][Full Text] [Related]
3. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
4. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
Ringborg A; Martinell M; Stålhammar J; Yin DD; Lindgren P
Int J Clin Pract; 2008 May; 62(5):708-16. PubMed ID: 18355236
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and incidence of Type 2 diabetes and its complications 1996-2003--estimates from a Swedish population-based study.
Ringborg A; Lindgren P; Martinell M; Yin DD; Schön S; Stålhammar J
Diabet Med; 2008 Oct; 25(10):1178-86. PubMed ID: 19046196
[TBL] [Abstract][Full Text] [Related]
6. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
[TBL] [Abstract][Full Text] [Related]
7. Is fenofibrate a cost-saving treatment for middle-aged individuals with type II diabetes? An economic analysis of the FIELD Study.
Carrington M; Stewart S
Int J Cardiol; 2008 Jun; 127(1):51-6. PubMed ID: 17586072
[TBL] [Abstract][Full Text] [Related]
8. The influence of a history of diabetes on treatment and outcome in acute myocardial infarction, during two time periods and in two different countries.
Svensson AM; Dellborg M; Abrahamsson P; Karlsson T; Herlitz J; Duval SJ; Berger AK; Luepker RV
Int J Cardiol; 2007 Jul; 119(3):319-25. PubMed ID: 17067706
[TBL] [Abstract][Full Text] [Related]
9. Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes.
Alserius T; Hammar N; Nordqvist T; Ivert T
Am Heart J; 2006 Sep; 152(3):599-605. PubMed ID: 16923437
[TBL] [Abstract][Full Text] [Related]
10. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
Stenestrand U; Lindbäck J; Wallentin L;
Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
[TBL] [Abstract][Full Text] [Related]
12. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes.
Mody R; Kalsekar I; Kavookjian J; Iyer S; Rajagopalan R; Pawar V
J Diabetes Complications; 2007; 21(2):75-83. PubMed ID: 17331855
[TBL] [Abstract][Full Text] [Related]
13. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
14. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
Boccuzzi SJ; Martin J; Stephenson J; Kreilick C; Fernandes J; Beaulieu J; Hauch O; Kim J
Curr Med Res Opin; 2009 Dec; 25(12):2853-64. PubMed ID: 19916729
[TBL] [Abstract][Full Text] [Related]
15. Saving lives, money and resources: drug and CABG/PCI use after myocardial infarction in a Swedish record-linkage study.
Wilhelmsen L; Welin L; Odén A; Björnberg A
Eur J Health Econ; 2010 Apr; 11(2):177-84. PubMed ID: 19495819
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of cardiovascular outcomes in patients with type 2 diabetes mellitus after the first acute myocardial infarction.
Moejko-Pastewka B; Tatoń J; Haczyński J; Strojek K; Ametov AS; Milicevic Z
Acta Diabetol; 2003 Dec; 40 Suppl 2():S354-7. PubMed ID: 14704868
[TBL] [Abstract][Full Text] [Related]
17. [Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study].
Liebl A; Spannheimer A; Reitberger U; Görtz A
Med Klin (Munich); 2002 Dec; 97(12):713-9. PubMed ID: 12491064
[TBL] [Abstract][Full Text] [Related]
18. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
[TBL] [Abstract][Full Text] [Related]
19. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
20. Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin.
Juhaeri J; Gao S; Dai WS
Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):497-503. PubMed ID: 19326365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
